Concepedia

M. OʼReilly

MO

Statistics

Publications

12

Citations

7.3K

H-Index

12

Active since

1994

Affiliations

Boston Children's Hospital(Current)

Harvard University

The University of Texas MD Anderson Cancer Center

Cancer Support Community

Harvard University Press

M. OʼReilly is an author at Boston Children's Hospital specializing in medicine, oncology, and angiogenesis.

Publications per year

1994–2013

12

Publications

12

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

M. OʼReilly · Cell · 1994 · 3.4K citations

, , +14

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Timothy M. Browder, Catherine Butterfield, Birgit M. Kräling et al. · PubMed · 2000 · 1.6K citations

, , +16

Inhibition of Angiogenesis In Vivo by Interleukin 12

Emile E. Voest, B. M. Kenyon, M. OʼReilly et al. · JNCI Journal of the National Cancer Institute · 1995 · 728 citations

, , +16

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

Sareh Parangi, M. OʼReilly, Gerhard Christofori et al. · Proceedings of the National Academy of Sciences · 1996 · 343 citations

, , +17

Vascular Endothelial Growth Factor/Vascular Permeability Factor is Temporally and Spatially Correlated with Ocular Angiogenesis In a Primate Model

Joan W. Miller, Anthony P. Adamis, DT SHIMA et al. · Retina · 1995 · 297 citations

, , +12

1–5 of 12